Circular No. 42/2010/TT-BYT promulgating the list of pharmaceutical đã được thay thế bởi Circular No. 09/2015/TT-BYT stipulating the approval for contents of advertisements for special products và được áp dụng kể từ ngày 16/07/2015.
Nội dung toàn văn Circular No. 42/2010/TT-BYT promulgating the list of pharmaceutical
THE MINISTRY OF HEALTH | SOCIALIST REPUBLIC OF VIET NAM |
No. 42/2010/TT-BYT | Hanoi, December 15, 2010 |
CIRCULAR
PROMULGATING THE LIST OF PHARMACEUTICAL ACTIVE SUBSTANCES AND MEDICINAL HERBS PERMITTED TO BE REGISTERED FOR ADVERTISEMENT ON RADIO AND TELEVISION
Pursuant to the Decree No. 188/2007/ND-CP dated December 27, 2007 of Government regulating functions, tasks, powers and organizational structure of Ministry of Health;
Pursuant to the Pharmacy Law No. 34/2005/QH11 dated June 14, 2005;
The Ministry of Health issues and guides to implement “The list of pharmaceutical active substances and medicinal herbs permitted to be registered for advertisement on radio and television” as follows:
Article 1. Issue together with this Circular “The list of pharmaceutical active substances and medicinal herbs permitted to be registered for advertisement on radio and television, including:
1. The List of pharmaceutical active substances;
2. Regulations for medicinal herbs
Article 2. Interpretation of terms
1. Pharmaceutical active substances (also known as drugs) means: a substance or a mixture of substances which is active in treatment used for drug production
2. Drugs derived from medicinal plants mean: drug is produced from raw materials derived from nature of animal, vegetable or mineral.
Drugs with pure active substances extracted from medicinal herbs, drugs with combination of medicinal herbs and synthetic chemical active substances are not called drugs from medicinal herbs
Article 3. The principle to set up list:
1. List of pharmaceutical active substances and medicinal herbs permitted to be registered for advertisement on radio and television is set up on basis of no prescription drug list and specific criterions on pharmacological properties and safety of drug.
2. List of pharmaceutical active substances and medicinal herbs permitted to be registered for advertising on radio and television in accordance with actual of Vietnam's drug using, supplying and consistent with regulations on current drug advertisement information.
3. List of pharmaceutical active substances and medicinal herbs permitted to be registered for advertising on radio and television will be amended and supplemented in accordance with list of no-prescription in case where list of prescription is changed. When it is necessary, to ensure safety for user, some drugs that can be removed from list of active substances and medicinal herbs permitted to be registered for advertising on radio and television if there are detected seriously harmful effects.
Article 4. Selective criteria for pharmaceutical active substances
1. On the list of drugs without writing a prescription issued by the Ministry of Health are still valid.
2. Pharmaceutical active substance meets criteria of list of drugs without writing a prescription but it will not be selected if it includes at least one of the following characteristics:
- Topical, stay-in effect but are likely not control the amount of drug absorbed through skin.
- Appointed in treatment of common diseases, but these diseases include symptoms that easily confused with disease need to be a doctor’s visit.
- Having using dose / regimen / duration should be strictly obeyed if not, shall happen status of drug resistance.
-Safe to use short term but may be at risk in case of prolonged use.
Article 5. Application to list
List of pharmaceutical active substances and medicinal herbs permitted to be advertised on radio and television is one of the legal bases for registration, consideration of drug advertising dossier on radio and television.
Article 6. Provisions for implementation
1. This Circular takes effect 45 days after date of its signing. To annul the Decision No. 45/2007/QD-BYT of December 18, 2007 of the Minister of Health on promulgating list of pharmaceutical active elements and drugs registered for advertising on radio and television.
2. The content of drug advertisement on radio and television that had the receipt of advertisement registration dossier by the Department of Drug Administration before the effective date of this Circular will be continued advertising until the content of that drug advertisement unvalued.
3. Department of Drug Administration, units under the Ministry of Health, Departments of Health of provinces and cities directly under Central Government, Vietnam Pharmaceutical Corporation, pharmaceutical business-manufacturing enterprises, foreign company licensed activities in line of pharmacy is responsible for implementation of this Circular.
4. In the process of implementation, if problems arising to propose organizations and individuals to promptly inform to the Ministry of Health (Department of Drug Administration) for consideration and settlement. /.
| ON BEHALF OF MINISTER |
LIST
DRUGS AND HERBAL INGREDIENTS ALLOWED TO BE ADVERTISED ON RADIO AND TELEVISION
(Promulgated together with the Circular No. 42/2010/TT-BYT dated December 17, 2010)
1. List of drugs:
No. | Active ingredients | Routes of administration, dosage forms, dose and concentration limits | Notes |
1 | Acetylcystein | Oral: various forms |
|
2 | Acetylleucine | Oral administration: various forms |
|
3 | Acetylsalicylic acid (aspirin), isolated or combined with Vitamin C and/or citric acid and/or sodium bicarbonate and/or sodium salicylate | Oral administration: various forms Topical administration: various forms |
|
4 | Alginic acid (sodium alginate), isolated or in combination with compounds of aluminum or magnesium. | Oral administration: various forms |
|
5 | Amino acid, isolated or in combinations (including combination with vitamins, minerals, trace elements) | Oral administration: various forms | Indications: provide supplemental amino acids and vitamins for the body. |
6 | Aminobenzoic acid (para-aminobenzoic acid) | Oral administration: various forms |
|
7 | Benzoic acids, isolated or in combinations | Topical administration Oral administration: lozenges |
|
8 | Boric acid, isolated or in combinations | Topical administration Eye drops |
|
9 | Citric acid in combination with sodium or potassium salts | Oral administration: various forms |
|
10 | Cromoglicic acid and cromoglycates | Eye drops and nose drops with cromoglicic acid ≤ 2% |
|
11 | Dimecrotic acid | Oral administration: various forms |
|
12 | Folic acid, isolated or in combination with iron and/or B vitamins, minerals, sorbitol | Oral administration: various forms | Indications: prevention of anemia, nutritional supplements |
13 | Glycyrrhizinic acid (Glycyrrhizinate) in combination with other substances such as Chlorpheniramine maleate, Dl-methylephedrine, caffeine, etc. | Oral administration: various forms, including lozenges Topical administration |
|
14 | Mefanamic acid | Oral administration: various forms |
|
15 | Salicylic acid, isolated or in combinations in topical products (in combination with lactic acid, precipitated sulfur | Topical administration |
|
16 | Albendazole | Oral administration: various forms | Indications: deworming |
17 | Dichlorbenzyl alcohol, in combinations in lozenges | Oral administration: lozenge |
|
18 | Polyvinyl alcohol | Topical administration |
|
19 | Alimemazine tartrate (Trimeprazine tartrate) | Oral administration: various forms |
|
20 | Allantoin, in combinations in topical products (Cepae fluid; Heparin, etc.) | Topical administration |
|
21 | Allatoin in combination with vitamins and/or Chondroitin | Eye drops |
|
22 | Almagate | Oral administration: various forms |
|
23 | Ambroxol, isolated or in combinations in cough medicine, antipyretics, painkillers | Oral administration: various forms with limited concentrations of active ingredients: - Divided dose: Ambroxol chlorhydrate ≤ 30 mg/unit - Undivided dose: Ambroxol chlorhydrate ≤ 0.8% |
|
24 | Amyllase, isolated or in combination with Protease and/or Cellulase | Oral administration: various forms |
|
25 | Amylmetacresol, in combinations in lozenges (such as with essential oil, bacitracine, etc.) | Oral administration: lozenges |
|
26 | Argyrol | Eye drops Topical administration |
|
27 | Aspartame | Oral administration: various forms |
|
28 | Aspartate | Oral administration: various forms |
|
29 | Attapulgite | Oral administration: various forms |
|
30 | Azelastine | Eye drops, nose drops |
|
31 | Silver sulfadiazine | Topical administration |
|
32 | Bacillus clausii | Oral administration: various forms |
|
33 | Lyophilized bacillus subtilis | Oral administration: various forms with the following limits: |
|
34 | Bacitracin in combination with other drugs in lozenges (with neomycin sulfate, Amylocaine, Tixocortol, etc.) | Oral administration: lozenges | . |
35 | Benzalkonium, in combinations in topical products (with choline; salicylic acid; nystatin: Diiodohydroxyquinoline, etc.) in lozenges (with tyrothricine, bacitracin, essential oil, etc.) | Topical administration Oral administration: lozenges |
|
36 | Benzocaine, in combinations | Topical administration: various forms with Benzocaine ≤ 10%; Oral administration: lozenges |
|
37 | Benzoyl peroxide, isolated or in combination with iodine and/or sulfur | Topical administration: various forms with concentration ≤ 10% |
|
38 | Benzydamine HCl, isolated or in combinations | Topical administration: oral mucosa ointment, mouthwash, oral sprays Oral administration: lozenge |
|
39 | Benzydamine salicylate, isolated or in combinations | Oral administration: lozenge |
|
40 | Benzyl benzoate, in combinations in topical products (essential oil, Isopropyl, etc.) | Oral administration: various forms Transdermal patches |
|
41 | Berberine | Oral administration: various forms |
|
42 | Biclotymol, isolated or in combination with Enoxolon and/or Phenylephrine HCl and/or Chlorpheniramine maleate and/or essential oil | Oral administration: lozenge Nose drops Oral administration: lozenges |
|
43 | Bifonazole, isolated or in combination with urea | Oral administration: lozenge |
|
44 | Bisacodyl | Oral administration: various forms with concentrations of doses ≤ 10mg/unit |
|
45 | Boldin | Oral administration: various forms |
|
46 | Bromelain, isolated or in combination with Trypsin | Oral administration: various forms with the following limits: |
|
47 | Bromhexin HCl, isolated or in combination with cough medicines, antipyretics, painkillers (such as with Dextromethorphan HBr, Diphenhydramin, Guaiphenesin, etc.) | Oral administration: various forms with limited concentrations of Bromhexine HCl: - Divided dose: ≤ 8 mg/unit; - Undivided dose: ≤ 0.8% Rectal suppositories |
|
48 | Brompheniramine maleate, isolated or in combinations in cough medicine, antipyretics, painkillers | Oral administration: various forms with the following limits: |
|
49 | Bufexamac, isolated or in combinations in topical products and rectal suppositories (such as with Titan Dioxid, Bismuth, Subgallat, Lidocain, etc.) | Oral administration: lozenge Rectal suppositories |
|
50 | Butoconazol | Topical administration |
|
51 | Compounds of calcium (except for Calcitriol), isolated or in combination with Vitamin D and/or vitamins and/or Ipriflavon | Oral administration: various forms | Indications: providing supplemental calcium for the body |
52 | Compounds of aluminum, magnesium, calcium , isolated and in combinations | Oral administration: various forms | Indications: neutralizing gastric acid, treating duodenal and gastric ulcer and |
53 | Compounds of iron and/or in combination with folic acid, vitamin B12, ect. | Oral administration: various forms | Indications: preventing and treating anemia |
54 | Enzymes, isolated or in combination with vitamins | Oral administration: various forms |
|
55 | Bismuth salts | Oral administration: various forms |
|
56 | Magnesium salts | Oral administration: various forms | Indications: providing supplemental magnesium for the body, neutralizing gastric acid. |
57 | trace elements: chromium, copper, potassium, magnesium, manganese, sodium, etc. | Oral administration: various forms | Indications: providing supplemental minerals for the body, including combinations with vitamins. |
58 | Essential oils (Menthol, Pinene, Camphor; Cineol, Fenchone, Borneol, Anethol, Eucalyptol...) | Oral administration: various forms Topical administration: topical ointment, mouthwash, oral mucosa ointment |
|
59 | Calamine, isolated or in combinations in topical products | Topical administration |
|
60 | Carbinoxamine, isolated or in combination with cough medicines, antipyretics, painkillers (with Pseudoephedrine HCl and/or Bromhexin and/or Paracetamol) | Oral administration: various forms with limited concentrations of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit; - Undivided dose: ≤ 0.5% |
|
61 | Carbocystein | Oral administration: various forms |
|
62 | Carbomer | Topical administration Eye drops |
|
63 | Catalase, isolated or in combinations in topical products (with Neomycin) | Topical administration |
|
64 | Cetirizine dihydrocloride | Oral administration: various forms |
|
65 | Cetrimide in combination with other substances in topical products (Lidocain, zinc, Calamine, Aminacrine, essential oil etc.) | Topical administration |
|
66 | Cetrimonium, in combinations in topical products and lozenges (in combination with Lidocain; Tyrothricin, essential oil, etc.) | Topical administration Oral administration: lozenges |
|
67 | Chitosan (Polyglusam) | Topical administration |
|
68 | Choline, isolated or in combination with amino acids and vitamins in orally administered products; in combination with salicylic acids, benzalkonium, etc. in topical products | Oral administration: various forms Topical administration |
|
69 | Chondroitin, isolated or in combination with glucosamine and/or fish oil and/or vitamins and/or amino acids | Oral administration: various forms
|
|
70 | Chondroitin in combination with vitamins | Nose drops with a concentration ≤ 0.5% |
|
71 | Chondroitin, in combinations in topical products | Oral administration: lozenge |
|
72 | Ciclopirox olamin | Topical administration |
|
73 | Cinnarizin | Oral administration: various forms |
|
74 | Cinchocain, in combinations in topical products (such with hydrocortison, neomycin, esculin, etc.) | Topical administration |
|
75 | Citrulline | Oral administration: various forms |
|
76 | Chlorhexidine | Topical administration |
|
77 | Chlorophyll | Oral administration: various forms |
|
78 | Chlorpheniramine maleate, isolated or in combination with cough medicines, antipyretics, painkillers (with Phenylephrine HCl, Paracetamol, Dextromethorphan HBr, etc.) | Oral administration: various forms. Divided-dose isolated substance: Chlorpheniramine maleate < 4mg/unit. |
|
79 | Chlorpheniramine maleate in combination with chondroitin and/or vitamins | Eye drops |
|
80 | Chlotrimazole | Topical administration: various forms with concentration ≤ 3% |
|
81 | Coenzym Q10, isolated or in combination with vitamins | Oral administration: various forms |
|
82 | Crotamiton | Topical administration |
|
83 | Copper sulfate | Topical administration |
|
84 | Dequalinium, isolated or in combinations in topical products and lozenges (Tyrothricin; hydrocortison; Glycyrrhetinic acid; Lidocain...), etc.) | Topical administration Oral administration: lozenges |
|
85 | Dexbrompheniramine maleate, isolated or in combinations in cough medicine, antipyretics, painkillers | Oral administration: various forms |
|
86 | Dexchlorpheniramine maleate, isolated or in combinations in cough medicine, antipyretics, painkillers | Oral administration: various forms |
|
87 | Dexibuprofen | Oral administration: various forms |
|
88 | Dexpanthenol | Eye drops Topical administration |
|
89 | Dextromethorphan HBr, isolated or in combinations in cough medicine, antipyretics, painkillers | Oral administration: various forms with the limited concentrations (in base form): - Divided dose: Dextromethophan ≤ 15mg - Undivided dose: Dextromethophan ≤ 0.6% | . |
90 | Diclofenac, isolated or in combination with methyl salicylate, essential oil, etc. | Topical administration Eye drops (isolated substances) |
|
91 | Dicyclomine | Oral administration: various forms |
|
92 | Diethylphtalate (DEP) | Topical administration |
|
93 | Dimenhydrinate | Oral administration: various forms |
|
94 | Dimethicone (Dimethylpolysiloxane), isolated or in combination with Guaiazulene | Oral administration: various forms |
|
95 | Dimethicone, in combinations in topical products (with zinc, calamine, cetrimide, etc.) | Topical administration |
|
96 | Dimetinden | Oral administration: various forms Topical administration |
|
97 | Disodium inosine monophosphate | Eye drops |
|
98 | Diosmectite (Dioctahedral smectite) | Oral administration: various forms |
|
99 | Diosmin in combination with hesperidin and/or some medicinal herbals that contain flavonoid | Oral administration: various forms |
|
100 | Diphenhydramine hydrochloride or monocitrate | Oral administration: various forms with limited concentrations (in base form): - Divided dose: ≤ 50 mg/unit; - Undivided dose: ≤ 2.5% |
|
101 | Domperidon | Oral administration: various forms with limited concentrations: - Divided dose: ≤ 10 mg/unit; - Undivided dose: ≤ 0.1% |
|
102 | Doxylamine, in combinations in cough medicines, antipyretics, painkillers (similarly to Paracetamol; Pseudoephedrine HCl; Dextromethorphan HBr; Vitamins, etc. | Oral administration: various forms with limited concentration of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit; - Undivided dose: ≤ 0.5% |
|
103 | Econazole | Topical administration |
|
104 | Enoxolone, isolated or in combinations in topical products and lozenges | Topical administration: topical ointment, mouthwash, oral mucosa ointment Oral administration: lozenges |
|
105 | Eprazinon | Oral administration: various forms |
|
106 | Esdepallethrin, in combinations in topical products (with essential oil, piperonyl, etc.) | Topical administration |
|
107 | Ethanol, isolated or in combinations | Topical administration (antiseptic alcohol) Oral administration: combinations |
|
108 | Etofenamate | Topical administration |
|
109 | Fenticonazole | Topical administration |
|
110 | Fexofenadine | Oral administration: various forms |
|
111 | Flurbiprofen | Lozenges Topical administration Eye drops |
|
112 | Glucosamine, isolated or in combination with Chondroitin and/or Vitamins | Oral administration: various forms |
|
113 | Glucose or dextrose, isolated or in combination with sodium or potassium salts | Oral administration: various forms | Indications: providing supplemental sugar and electrolytes |
114 | Glycerinw, isolated or in combinations in topical products and eye drops (with Polysorbate 80) | Oral administration: lozenge Nose drops with a concentration ≤ 0.5% |
|
115 | Glycerol, isolated or in combination with herbal extract. | Rectal enema |
|
116 | Guaiphenesin, isolated or in combinations in cough medicines, antipyretics, painkillers (with Paracetamol, Pseudoephedrine HCl, Dextromethorphan HBr, etc. | Oral administration: various forms with limited concentration of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit; - Undivided dose: ≤ 0.5% |
|
117 | Hexamidine, isolated or in combinations (with Cetrimide, Lidocain, Clotrimazole, Catalase) | Oral administration: lozenge |
|
118 | Hexetidine, isolated or in combinations (with Benzydamin, Cetylpyridinum, Choline Salicylat, Methyl salicylate, essential oil, etc.) | Topical administration: topical ointment, mouthwash |
|
119 | Hydrocortison, isolated or in combinations (with Miconazole, Econazole, Tioconazole, Neomycin) | Topical administration: various forms with hydrocortisone ≤ 0.5% |
|
120 | Hydrogen peroxide, isolated or in combination with sodium lauryl sulfat and/or essential oil, etc. | Oral administration: lozenge |
|
121 | Hydrotalcit | Oral administration: various forms |
|
122 | Hydroxypropyl methylcellulose (HPMC) | Eye drops |
|
123 | Hypromellose, isolated or in combination with Dextran 70 | Eye drops: various forms |
|
124 | Ibuprofen | Oral administration: various forms Topical administration |
|
125 | Ichthammol | Topical administration |
|
126 | Iodine, isolated or in combination with benzoic acid and/or salicylic acid | Topical administration with iodine ≤ 5% |
|
127 | Isoconazole | Topical administration |
|
128 | Isopropyl Methylphenol | Topical administration |
|
129 | Ketoconazole, isolated or in combination with zinc pirythione and/or hydrocortison and/or trolamine | Topical administration: various forms with Ketoconazole ≤ 2% |
|
130 | Ketoprofen | Topical administration |
|
131 | Zinc oxide, zinc pyrithione, zinc gluconate, zinc undecylenate, isolated or in combination with topical products | Topical administration |
|
132 | Zinc sulfat | Topical administration Eye drops |
|
133 | Lactic acid bacillus, isolated or in combination with vitamins | Oral administration: various forms |
|
134 | Lactitol | Oral administration: various forms |
|
135 | Lactobacillus acidophilus | Oral administration: various forms |
|
136 | Lactobacillus acidophilus, isolated or in combination with vitamins | Oral administration: various forms |
|
137 | Lactoserum atomisate (Lactacyd) | Topical administration |
|
138 | Lactulose | Oral administration: various forms |
|
139 | Levocetirizine | Oral administration: various forms |
|
140 | Lindan (Benhexachlor, 666, Gamma-BHC), isolated or in combination with lidocain | Topical administration with Lindan ≤ 1% |
|
141 | Loratadine, isolated | Oral administration: various forms with the following limited concentration (in base form): - Divided dose: Loratadine ≤ 10mg/unit; - Undivided dose: Loratadine ≤ 0.1% |
|
142 | Loxoprofen | Oral administration: various forms |
|
143 | Lysozyme, isolated or in combination with Tocopherol, Nicotinate, Carbazochrome, Inositol Cetylpyridinium, etc. | Oral administration: various forms Topical administration
|
|
144 | Macrogol | Oral administration: various forms Rectal enema |
|
145 | Magaldrate, isolated or in combination with aluminum, magnesium, alginic acid (or alginate salts) | Oral administration: various forms |
|
146 | Mangiferin | Topical administration |
|
147 | Mebendazole | Oral administration: various forms with limited concentrations: - Divided dose: ≤ 500 mg/unit - Undivided dose: ≤ 2% |
|
148 | Cellulase fongique | Oral administration: various forms |
|
149 | Menthol in combination with other substances such as essential oil mixture, methyl salicylate, etc. | Oral administration: various forms Topical administration: various forms |
|
150 | Mequinol | Topical administration |
|
151 | Mequitazine | Oral administration: various forms Topical administration |
|
152 | Methyl salicylate, in combinations in topical products (in combination with essential oil, etc.) | Topical administration Transdermal patches Oral administration: lozenges |
|
153 | Metronidazole | Topical administration |
|
154 | Miconazole | Topical administration Vaginal cream ≤ 2% |
|
155 | Minoxidil | Topical administration: various forms with concentration ≤ 5% |
|
156 | Mupirocin | Topical administration |
|
157 | Myrtol, isolated or in combinations in lozenges | Oral administration: various forms Topical administration |
|
158 | Naphazoline, in combinations in eye drops, (Pheniramine; Vitamin glycyrhizinate, Dexpanthenol, etc.) | Eye drops: various forms with Naphazoline ≤ 0.1% |
|
159 | Naproxen | Oral administration: various forms with divided-dose Naproxen ≤ 250mg/unit |
|
160 | Sodium benzoate, isolated or in combinations | Oral administration: various forms |
|
161 | Sodium bicarbonate, isolated or in combinations | Oral administration: various forms |
|
162 | Sodium carbonate, isolated or in combinations | Oral administration: various forms |
|
163 | Sodium Carboxymethylcellulose (Na CMC) | Eye drops |
|
164 | Sodium chloride, isolated or in combination with potassium citrate, sodium citrate, etc. | Oral administration: various forms Topical administration Eye drops, nose drops |
|
165 | Sodium docusate | Oral administration: various forms |
|
166 | Sodium fluoride, in combinations | Topical administration: toothpaste, mouthwash |
|
167 | Sodium hyaluronate (Hyaluronic acid) | Topical administration |
|
168 | Sodium monofluorophosphate | Topical administration: toothpaste, mouthwash |
|
169 | Sodium salicylate, in combinations | Oral administration: in combinations in lozenges Topical administration |
|
170 | Neomycin sulfate, in combinations in lozenges (zinc, bacitracin, amylocaine, etc.) and topical products | Oral administration: lozenges Topical administration |
|
171 | Nomahydrated sodium Sulfide + Saccharomyces Cerevisiae | Oral administration: various forms Topical administration |
|
172 | Nystatin, isolated or in combinations | Topical administration |
|
173 | Ossein hydroxyapatite | Oral administration: various forms |
|
174 | Oxeladin | Oral administration: various forms |
|
175 | Oxymemazine | Oral administration: various forms |
|
176 | Oxymetazoline | Nose drops with a concentration ≤ 0.5% |
|
177 | Pancreatin, isolated or in combination with Simethicone and/or enzymes and/or B vitamins and/or Azintamide | Oral administration: various forms | . |
178 | Panthenol | Topical administration Eye drops |
|
179 | Paracetamol | Oral administration: various forms Rectal suppositories | In combinations specified in the list |
180 | Paracetamol in combination with Ibuprofen and/or Caffeine | Oral administration: various forms |
|
181 | Paracetamol in combination with Loratadine and/or Dextromethorphan HBr | Oral administration: various forms |
|
182 | Paracetamol in combination with Pseudoephedrine HCl and/or vitamin C and/or one of the substances below: Brompheniramine maleate; Chlorpheniramine maleate; Pheniramine maleate; Dexclorpheniramine maleate; Dexbrompheniramin maleate; Dextromethorphan HBr; Phenylephrine HCl | Oral administration: various forms with limited concentrations (in base form): - Divided dose: Pseudoephedrine ≤ 120 mg/unit Dextromethophan ≤ 15mg/unit - Undivided dose: Pseudoephedrine ≤ 0.5% Dextromethophan ≤ 0.6% |
|
183 | Pentoxyverine | Oral administration: various forms |
|
184 | Phenylephrine HCl, in combinations in topical products (such as Petrolatum sperti yellow; Mineral oil light; Shark liver oil, etc.) | Topical administration | . |
185 | Phenylephrine HCl in combination with cough medicines, antipyretics, and painkillers | Oral administration: various forms Rectal suppositories |
|
186 | Phospholipid | Oral administration: various forms |
|
187 | Picloxydin | Eye drops |
|
188 | Piroxicam | Topical administration: various forms with concentration ≤ 1% |
|
189 | Policresulen (Metacresol sulphonic acid-formaldehyde) | Topical administration Rectal suppositories |
|
190 | Polymethylene glycol 400, isolated or in combination with propylene glycol | Eye drops |
|
191 | Polysaccharide | Oral administration: various forms |
|
192 | Polytar, isolated or in combinations in topical products (such as zinc pyrithione, etc.) | Topical administration
|
|
193 | Povidone Iodine | Topical administration: various forms, including mouthwash ≤ 1% Eye drops |
|
194 | Pseudoephedrine HCl in combination with Cetirizin | Oral administration: various forms with limited concentrations of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit - Undivided dose: ≤ 0.5% |
|
195 | Phenylephrine HCl, in combinations in cough medicines, antipyretics, and painkillers | Oral administration: various forms with limited concentrations of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit; - Undivided dose: ≤ 0.5% |
|
196 | Pyrantel | Oral administration: various forms | Indications: deworming |
197 | Rutin, isolated or in combination with vitamin C and/or herbal extract | Oral administration: various forms |
|
198 | Saccharomyces boulardic | Oral administration: various forms |
|
199 | Saccharomyces cerevisiae + Magnesium sulfate trihydrate | Oral administration: various forms |
|
| Organic selenium, in combinations in products that contain vitamins and minerals | Oral administration: various forms with limited concentrations: - Divided dose: selenium ≤ 120 mcg/unit |
|
200 | Selenium sulfide | Topical administration |
|
201 | Silymarin, isolated or in combination with vitamins and/or herbal extract | Oral administration: various forms |
|
202 | Simethicone, isolated or in combination with pancreatin and/or deoxycholic acid and/or B vitamins and/or enzymes | Oral administration: various forms |
|
203 | Simethicone in combination with compounds of aluminum, magnesium, and/or dicyclomine and activated carbon | Oral administration: various forms |
|
204 | Sorbitol, isolated or in combinations | Oral administration: various forms |
|
205 | Sterculia (gum sterculia) | Oral administration: various forms Rectal enema |
|
206 | Sucralfate | Oral administration: various forms |
|
207 | Sulbutiamine | Oral administration: various forms |
|
208 | Sulfogaiacol, isolated or in combinations in cough medicines, antipyretics, painkillers (such as in combination with sodium benzoate, dextromethophan, etc.) | Oral administration: various forms |
|
209 | Terbinafin | Topical administration: various forms with concentration ≤ 1% |
|
210 | Terpin, isolated | Oral administration: various forms. |
|
211 | Tetrahydrozoline | Nose drops |
|
212 | Activated carbon, isolated or in combination with simethicone | Oral administration: various forms |
|
213 | Tioconazole, isolated or in combination with hydrocortison | Topical administration: various forms with limited concentrations: - Tioconazole ≤ 1.00% - Hydrocortison ≤ 0.05% |
|
214 | Tolnaftate | Topical administration |
|
215 | Triclosan, isolated or in combinations in topical products | Topical administration |
|
216 | Triprolidine, isolated or in combinations in cough medicines, antipyretics, painkillers (such as with guaiphenesine, paracetamol, pseudoephedrine HCl, dextromethorphan HBr, etc.) | Oral administration: various forms with limited concentrations of Pseudoephedrine (in base form): - Divided dose: ≤ 120 mg/unit; - Undivided dose: ≤ 0.5% |
|
217 | Trolamine, isolated or in combinations in topical products (with triclosan and/or tyrothricin) | Topical administration |
|
218 | Tyrothricin, in combinations (with benzalkonium, benzocaine, formaldehyde, trolamin, essential oil, etc.) | Oral administration: lozenges Topical administration: mouthwash, oral ointment |
|
219 | Urea, isolated or in combination with vitamin E and/or bifonazol and/or herbal ingredients (aloe extract, etc.) | Topical administration |
|
220 | Vitamin A and provitamin A (Beta-carotene) | Oral administration: various forms with vitamin A ≤ 5000 IU/divided dose. Topical administration Eye drops |
|
221 | B vitamins, vitamin PP, isolated or in combinations. | Eye drops |
|
222 | Vitamins and provitamins, isolated (except for vitamin A and vitamin d) or in combination with vitamins, minerals, amino acids, taurine, fatty acid. | Oral administration: vitamin A in combinations ≤ 5000 IU/divided dose. Topical administration | Providing supplemental vitamins, minerals, and nutrients. |
223 | Methylene blue | Topical administration |
|
224 | Xylometazoline, isolated or in combination with Benzalkonium | Nose drops with Xylometazoline ≤ 1% |
|
2. For medicinal herbs:
2.1. The medicinal herb without toxicities and/or without severe harmful effects that are known or warned may be advertised on radio and television.
2.2. The medicinal herbs with toxicities shall be considered in each particular drug.
The oriental medicines and drugs from medicinal herbs with toxicities, which are issued with registration numbers by the Ministry of Health, and of which the effects and indications have been approved and are conformable with the Circular on advertising drugs issued by the Ministry of Health, may be advertised on radio and television.
------------------------------------------------------------------------------------------------------
This translation is made by LawSoft and for reference purposes only. Its copyright is owned by LawSoft and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed
